FOR IMMEDIATE RELEASE
May 1, 2026
Contact: media@bodymetrix.com
BodyMetrix Launches Direct-to-consumer Platform In North America, Positioning As The Category-defining Body Composition Intelligence Company
Twenty-two years of clinical validation. A substantial capital raise underway. A seasoned execution team. And the only platform that resolves the fundamental problem healthtech has never solved — accurate and accessible in body composition.
SAN FRANCISCO, CA — May 1, 2026 — IntelaMetrix Holdings, Inc., the parent company of BodyMetrix, today announced the North America direct-to-consumer launch of the BodyMetrix platform. The launch marks the beginning of a full platform transition from legacy hardware to an integrated device-plus-SaaS subscription model — and positions BodyMetrix to become the category-defining body composition intelligence company of the next decade.
The Problem Healthtech Has Not Solved
Body composition is one of the most clinically significant metrics in human health and performance — and one of the most poorly measured. The tools available to working professionals have always forced a choice: accurate or accessible. Not both.
No company has built the platform that delivers clinical-grade body composition measurement at the accessibility, portability, and scale the market demands. That is the gap BodyMetrix was built to fill — twenty-two years ago — and the opportunity the company is now positioned to own.
"Look at what Dexcom did for continuous glucose monitoring or what ResMed did for sleep apnea," said Drew Stark, Founder, CEO, and President of IntelaMetrix Holdings. "Both took a clinical measurement problem that had no accessible solution, built a platform around it, and became the category standard. Body composition is that opportunity right now. The hard part of a startup is already done — the technology is proven, the clinical validation exists, and the market is using it. This is not a product bet. It is an execution bet. And we have assembled the team, capital, and the infrastructure to win it."
A Standard Built Over Two Decades
BodyMetrix was founded in September 2004 by Dr. Luiz da Silva — a world-renowned biophysicist, Fellow of the American Physical Society and the Optical Society of America, and holder of more than 50 patents and 200 peer-reviewed publications. Dr. da Silva invented the BodyMetrix BX2K ultrasound body composition platform alongside his son, Drew Stark, while Drew was just graduating high school — applying the same A-mode ultrasound science the USDA had used for decades to measure tissue composition in livestock to human body composition assessment for the first time at professional scale.
Over the two decades that followed, BodyMetrix accumulated 50+ peer-reviewed clinical studies, earned FDA Class I clearance, assessed over 2.1 million clients, and built a global install base of 14,000+ providers across professional sports, elite fitness, sports medicine, wellness, and youth athletics settings worldwide. The platform became the recognized compliance standard for wrestling weight management programs under CIF and NJSIAA — and is currently positioned to receive NFHS national recommendation for high school sports across the US.
A Return Driven By Purpose
In 2020s, Dr. Da Silva was diagnosed with Early Onset Alzheimer's Disease. In Spring of 2025, Heidi Stark — co-founder, and the company's CFO and COO since its founding — was diagnosed with Breast Cancer. Both founders stepped back from daily operations. Heidi, now in remission, serves today as a Board Member of IntelaMetrix Holdings, Inc. and transition advisor.
Drew Stark returned to IntelaMetrix in July 2025. Not to sell the company. To rebuild it.
He analyzed the asset — thousands of deployed devices, scores peer-reviewed studies, regulatory clearance, and a global provider base that had never stopped using the platform — and saw what the circumstances had obscured. BodyMetrix was not a distressed company. It was an undervalued one. The foundation was exceptional. What it needed was leadership, a modern operating model, and a growth plan built for where the market is going.
"My parents built something very special — a clinical standard with two decades of peer-reviewed validation behind it, trusted by 14,000 providers across every professional setting that depends on accurate body composition data," said Stark. "When both of them stepped back, I had a choice. Sell the company or finish what we started. I came back to finish it — and to build what the platform was always capable of becoming."
The Execution Bet — A Team Built For Scale
Stark's thesis from the beginning has been clear: the hard part of a startup is proving the technology works in market. BodyMetrix cleared that bar two decades ago. What this moment requires is not invention — it is execution. To that end, Stark has assembled a founding leadership team of seasoned operators and engaged a best-in-class partner ecosystem purpose-built for the platform transition.
Bryan Taylor joins as Co-Founder and Chief Platform Officer, bringing 25+ years of executive experience in technology infrastructure, systems management, and application development — including roles on acquisition leadership teams for several enterprise fitness organizations. Taylor was initially contacted as a trusted technical sounding board as Stark evaluated the BodyMetrix opportunity. After conducting his own due diligence on the platform, the install base, and the data asset, Taylor made the case for joining as a co-founder and platform architect.
"The clinical validation, the install base, the 20 years of body composition data sitting inside 14,000 deployed devices — the foundation was exceptional," said Taylor. "The opportunity was to build the platform that makes all of it actionable at scale. That kind of opportunity does not come along often. When it does, you move."
Jacob Uyeyama joins as Co-Founder, COO, and Vice President, a seasoned healthcare operator with acquisitions experience in private equity. Uyeyama owns day-to-day operations, manufacturing, and the supply chain and logistics infrastructure supporting the D2C launch and global expansion.
The leadership team is supported by a partner ecosystem assembled for execution at scale: Burkland Associates for financing and accounting infrastructure, LabSmith for manufacturing and hardware engineering, Stephen Gould, global leader in packaging and fulfillment, for device packaging and supply chain execution, and Wilson Sonsini for intellectual property counsel.
The Problem Healthtech Has Not Solved
Body composition is one of the most clinically significant metrics in human health and performance — and one of the most poorly measured. The tools available to working professionals have always forced a choice: accurate or accessible. Not both.
No company has built the platform that delivers clinical-grade body composition measurement at the accessibility, portability, and scale the market demands. That is the gap BodyMetrix was built to fill — twenty-two years ago — and the opportunity the company is now positioned to own.
"Look at what Dexcom did for continuous glucose monitoring or what ResMed did for sleep apnea," said Drew Stark, Founder, CEO, and President of IntelaMetrix Holdings. "Both took a clinical measurement problem that had no accessible solution, built a platform around it, and became the category standard. Body composition is that opportunity right now. The hard part of a startup is already done — the technology is proven, the clinical validation exists, and the market is using it. This is not a product bet. It is an execution bet. And we have assembled the team, capital, and the infrastructure to win it."
About BodyMetrix
BodyMetrix is the clinical-grade body composition platform built for the professionals who cannot afford to be wrong. Validated in 50+ peer-reviewed clinical studies, FDA Class I cleared, over 2 million clients assessed, and trusted by 14,000+ providers across professional sports, elite fitness, sports medicine, wellness, and youth athletics worldwide.
BodyMetrix is a product of IntelaMetrix Holdings, Inc., a Delaware corporation.
For media inquiries: media@bodymetrix.com